The importance of early detection of cancer cannot be over stated. But, as the world went into lockdown due to COVID-19, the push for early detection was put to the test. The fear of contracting COVID-19 at hospitals and clinics overwhelmed people and became a powerful deterrent to patients seeking screening, getting a check-up when symptoms appeared and even staying on existing cancer treatment plans. In this brief, learn how AstraZeneca moved quickly to launch a series of programs to mitigate the impact of COVID-19, working in partnership with the cancer community to continue care for patients while maintaining momentum around screening and early diagnoses. In the face of very challenging circumstances, the company has identified unique opportunities to evolve cancer care in ways that will have a positive and lasting impact.
For more information on the annual Top 10 Medical Innovations list including descriptions, videos, and year-by-year comparisons visit: https://innovations.clevelandclinic.org/Programs/Top-10-Medical-Innovations
▶Share this video with others: https://youtu.be/wS94NS71pX4
▶Subscribe to learn more about Cleveland Clinic: https://www.youtube.com/user/ClevelandClinic?sub_confirmation=1
For more information on the annual Top 10 Medical Innovations list including descriptions, videos, and year-by-year comparisons visit: https://innovations.clevelandclinic.org/Programs/Top-10-Medical-Innovations
▶Share this video with others: https://youtu.be/wS94NS71pX4
▶Subscribe to learn more about Cleveland Clinic: https://www.youtube.com/user/ClevelandClinic?sub_confirmation=1
